Back

The efficacy and safety of bamlanivimab treatment against COVID-19: A meta-analysis

2021-08-26 pharmacology and therapeutics Title + abstract only
View on medRxiv
Show abstract

BackgroundBamlanivimab is routinely used in the treatment of coronavirus disease 2019 (COVID-19) in worldwide. We performed a meta-analysis to investigate the efficacy and safety of bamlanivimab treatment in patients with COVID-19. MethodsWe searched articles from Web of Science, PubMed, Embase, the Cochrane Library and MedRxiv between 30 January 2020 and August 5, 2021. We selected randomized clinical trials (RCTs) and observational studies with a control group to assess the efficiency of baml...

Predicted journal destinations

1
Clinical Pharmacology & Therapeutics
19 training papers
Top 0.2% 12.4%
2
Frontiers in Pharmacology
27 training papers
#1 9.8%
3
PLOS ONE
1737 training papers
Top 65% 8.2%
4
Scientific Reports
701 training papers
Top 25% 8.2%
5
Frontiers in Medicine
99 training papers
Top 0.1% 8.2%
6
British Journal of Clinical Pharmacology
21 training papers
Top 0.5% 6.3%
7
Nature Communications
483 training papers
Top 32% 2.9%
8
New England Journal of Medicine
49 training papers
Top 0.9% 2.0%
9
Antimicrobial Agents and Chemotherapy
17 training papers
#1 2.0%
10
eLife
262 training papers
Top 20% 2.0%
11
Vaccines
131 training papers
Top 4% 2.0%
12
Clinical Infectious Diseases
219 training papers
Top 17% 1.6%
13
BMJ
49 training papers
Top 3% 1.4%
14
Clinical Microbiology and Infection
54 training papers
Top 4% 1.4%
15
Trials
24 training papers
Top 0.9% 1.4%
16
Frontiers in Immunology
140 training papers
Top 8% 1.4%
17
BMC Infectious Diseases
110 training papers
Top 14% 1.4%
18
Journal of Clinical Medicine
77 training papers
Top 13% 1.4%
19
Med
26 training papers
Top 0.3% 1.2%
20
The Journal of Infectious Diseases
137 training papers
Top 12% 1.2%
21
BMJ Open
553 training papers
Top 62% 1.0%
22
Infectious Diseases and Therapy
18 training papers
Top 0.4% 1.0%
23
PLOS Medicine
95 training papers
Top 16% 1.0%
24
Cureus
64 training papers
Top 21% 0.8%
25
Vaccine
140 training papers
Top 10% 0.8%
26
Journal of Antimicrobial Chemotherapy
19 training papers
Top 0.8% 0.8%